| Old Articles: <Older 9181-9190 Newer> |
|---|
 |
Chemistry World
November 9, 2015
Rebecca Trager |
Pharma kickback claims lead to individual prosecutions Two pharmaceutical powerhouses will have to pay hundreds of millions of dollars to address US government claims that they gave kickbacks to physicians to induce them to prescribe their drugs.   |
Chemistry World
November 4, 2015
Phillip Broadwith |
Shire to buy cardiovascular specialist Dyax The deal gives Shire access to Dyax's portfolio of approved and developmental drugs for treating hereditary angioedema. |
Fast Company
Ungerleider &Tetzeli |
Theranos CEO Tried To Take Control From Stockholders In Late 2013 In the shareholder letter, Elizabeth Holmes asked investors to agree to a stock split and to the creation of two classes of common stock that would give her voting control over Theranos. |
Chemistry World
November 3, 2015
Phillip Broadwith |
Bristol-Myers Squibb to buy Cardioxyl for heart drug The deal gives BMS full rights to develop CXL-1427, an experimental drug for acute decompensated heart failure, currently in Phase II clinical trials. |
AskMen.com
October 30, 2015
Asandra & Palubicki |
Are Erectile Dysfunction Supplements Dangerous? Here's why erectile dysfunction supplements can be extremely dangerous. |
CIO
October 29, 2015
Martha Heller |
Amgen uses algorithms to venture into digital healthcare A senior vice president of global marketing and commercial development, says she's working with the CIO to set up a digital healthcare organization that can help physicians better predict how patients will respond to therapies. |
Chemistry World
October 29, 2015
Anthony King |
Poor diagnostics hinder battle against antibiotic resistance The tools used to diagnose bacterial infections have barely improved since the 1940s. |
Information Today
October 29, 2015 |
Thomson Reuters Streamlines Healthcare Industry Analysis Thomson Reuters rolled out the Healthcare Intelligence application for Thomson Reuters Eikon to improve workflow for financial professionals. |
Chemistry World
October 28, 2015
Phillip Broadwith |
Job cuts at Daiichi, Perrigo and Cabot Three pharma firms -- Daiichi Sankyo, Perrigo and Allergan -- and specialty chemicals company Cabot are to cut thousands of jobs between them in restructuring efforts. |
Fast Company
Pavithra Mohan |
Another Blow to Theranos: Blood Vial Deemed "Uncleared Medical Device" By FDA In another blow to embattled blood testing startup Theranos, the FDA posted inspection reports on Tuesday that reveal potentially disastrous pitfalls for the company. |
| <Older 9181-9190 Newer> Return to current articles. |
